HITRUST CSF Certified Logo

Biomedix Expands HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST CSF Certification validates Biomedix is committed to meeting key regulations and protecting sensitive information. St Paul, MN, November 30th – Biomedix, a healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation Read more…

Upcoming Webinar: Advancing Healthcare Equity By Addressing the Amputation Epidemic

A major consequence of racism in healthcare is the increased rate of adverse outcomes of chronic conditions in minority populations. Non-traumatic lower-extremity amputations are just one of the major adverse outcomes more likely to happen to patients in under-served communities. These amputations carry high risks of mortality, related complications, and Read more…

O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

Biomedix to offer a free O’Brien ETF128 tuning fork with PADnet purchases for Diabetes Awareness Month

In honor of Diabetes Awareness Month this November, Biomedix is inviting all healthcare professionals to optimize care for their diabetic patients through the earlier identification of related chronic complications such as Peripheral Artery Disease (PAD), and now Peripheral Neuropathy through a new partnership with O’Brien Medical. To build on our Read more…

Update: On-Demand Biomedix webinar on operationalizing PADnet in your practice

Join us for a webinar session to see how some successful PADnet® champions have operationally integrated PADnet vascular testing into their clinical workflow.During this roundtable-style webinar, we’ll review effective workflows for your practice to accelerate and simplify your use of PADnet. We’ll go over the patient experience before, during and Read more…